Advertisement

Chronic Effects of Alcohols on Mouse Biomembranes

  • Dora B. Goldstein
  • Jane H. Chin
  • Janet A. McComb
  • Linda M. Parsons
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 126)

Abstract

Our recent work has been directed at determining the role of membrane lipids in the chronic effects of ethanol. The hypothesis that alcohols act at hydrophobic sites has been in favor ever since the work of Meyer and Overton, because the aliphatic alcohols fit nicely on plots showing correlation of potency with lipid solubility (1). Much more recently, Seeman (2) has shown that ethanol and its close relatives expand the membranes of red blood cells, with potencies proportional to their lipid solubility in the membrane. Either the lipids or the hydrophobic portions of the proteins could be the site of action of alcohols in biomembranes. If lipid solubility determines potency, it follows that a membrane-acting drug should affect every cell in the body. Any specificity of action of such drugs very likely reflects the relative sensitivity of various cells to perturbations of their membranes. Neurons would be expected to be the most sensitive cells in the body, since their membranes perform all the functions of general transport and in addition must carry out ion transport with a speed and precision that seems beyond the abilities of other cell types. Some specificity may also be due to differential solubility of drugs in lipids of different composition. It now seems likely that there is a good deal of variety of membrane lipid composition, not only between cells but at different regions of the same cell. The subsynaptic membrane is likely to differ from the membrane of an axon. Microscopic inhomogeneities exist in the region of the membrane proteins, many of which are apparently surrounded by a layer of boundary lipid. Thus there are many possibilities for differential actions of a membrane-acting drug on different cells. It is easy to imagine how much more complicated this field of investigation will become when we get past the early exploratory stage and begin to deal with specific actions of drugs on different parts of membranes. But for the moment, it is of interest just to sketch out the outlines of what a drug might do if it acts simply by occupying space in cell membranes and thus disrupting the function of the embedded proteins.

Keywords

Electron Paramagnetic Resonance Physical Dependence Lipid Solubility Membrane Lipid Composition Alcohol Withdrawal Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Seeman, P. The membrane actions of anesthetics and tranquilizers. Pharm. Rev. 24: 583–655, 1972.PubMedGoogle Scholar
  2. 2.
    Seeman, P., Kwant, W.O., Sauks, T. and Argent, W. Membrane expansion of intact erythrocytes by anesthetics. Biochim. Biophys. Acta 183: 490–498, 1969.Google Scholar
  3. 3.
    McComb, J.A. and Goldstein, D.B. The production of physical dependence in mice with chronic tertiary butanol treatment. Ale. Clin. Exp. Res. 1: 152, 1977.Google Scholar
  4. 4.
    McComb, J.A. and Goldstein, D.B. The dose-response effects of short chain alcohols administered to mice intraperitoneally. Pharmacologist 17: 198, 1975.Google Scholar
  5. 5.
    Wallgren, H., Kosunun, A.-L. and Ahtee, L. Technique for producing an alcohol withdrawal syndrome in rats. Israel J. Med. Sci. 9 suppl.: 63–71, 1973.PubMedGoogle Scholar
  6. 6.
    Bellin, S.I. and Edmonds, H.L., Jr. The use of tert-butanol in alcohol dependence studies. Proc. West. Pharmacol. Soc. 19: 351–354, 1977.Google Scholar
  7. 7.
    Wood, J. and Laverty, R. Alcohol withdrawal syndrome following prolonged t-butanol administration to rats. Proc. Univ. Otago Med. Sci. 54: 86–87, 1976.Google Scholar
  8. 8.
    McComb, J.A. and Goldstein, D.B. Additive physical dependence on alcohols. Alc. Clin. Exp. Res. 2: 190, 1978.Google Scholar
  9. 9.
    Chin, J.H. and Goldstein, D.B. Effects of low concentrations of ethanol on the fluidity of spin-labeled erythrocyte and brain membranes. Mol. Pharmacol. 13: 435–441, 1977.PubMedGoogle Scholar
  10. 10.
    Goldstein, D.B. and Arnold, V.W. Drinking patterns as predictors of alcohol withdrawal reactions in DBA/2J mice. J. Pharmacol. Exp. Ther. 199: 408–414, 1976.PubMedGoogle Scholar
  11. 11.
    Chin, J.H. and Goldstein, D.B. Drug tolerance in biomembranes: A spin label study of the effects of ethanol. Science 196: 684–685, 1977.PubMedCrossRefGoogle Scholar
  12. 12.
    Oldfield, E. and Chapman, D. Dynamics of lipids in membranes: Heterogeneity and the role of cholesterol. FEBS Lett. 23: 285–297, 1972.PubMedCrossRefGoogle Scholar
  13. 13.
    Chin, J.H., Parsons, L.M. and Goldstein, D.B. Increased cholesterol content of erythrocyte and brain membranes in ethanol-tolerant mice. Biochim. Biophys. Acta, in press.Google Scholar
  14. 14.
    Littleton, J.M. and John, G. Synaptosomal membrane lipids of mice during continuous exposure to ethanol. J. Pharm. Pharmacol. 29: 579–580, 1977.PubMedCrossRefGoogle Scholar
  15. 15.
    Miller, K.W. and Yu, S.-C.T. The dependence of the lipid bilayer membrane:buffer partition coefficient of pentobarbitone on pH and lipid composition. Brit. J. Pharmacol. 61: 57–63, 1977.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Dora B. Goldstein
    • 1
  • Jane H. Chin
    • 1
  • Janet A. McComb
    • 1
  • Linda M. Parsons
    • 1
  1. 1.Department of PharmacologyStanford University School of MedicineStanfordUSA

Personalised recommendations